Quest Diagnostics Honored for Diagnostic Innovation at 2011 Edison Awards
MADISON, N.J., April 6, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa™ molecular test on the 3M™ Integrated Cycler was honored with a bronze award for best new science and medical diagnostic product during the 2011 Edison Awards gala ceremony last night in New York City. Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics, developed and provides the Simplexa line of molecular test products to laboratories internationally in collaboration with 3M.
"Passion for developing diagnostic innovations that will improve patient care is central to our culture and mission," said Surya N. Mohapatra, Ph.D., chairman and chief executive officer, Quest Diagnostics. "Winning the prestigious Edison award underscores the strength of our commitment to innovation and our patients while also marking the success of our close collaboration with 3M."
The Edison awards, named after the prolific inventor Thomas Alva Edison, are granted under the aegis of the Thomas A. Edison Papers at Rutgers University and sponsored by The Nielsen Company and Discovery Channel, among other companies. More than 2,000 marketing professionals and academics with the Marketing Executives Networking Group (MENG) select the best products based on criteria that include technological innovation, and market and social impact, and marketplace success. Last night's winners include the Apple iPad, the GE energy smart LED A19 Bulb, and Coca-Cola Freestyle®. For a complete list of winners, refer to: http://www.edisonawards.com/MediaRoom.php 
"Fast, quality test reporting is vital to patient care. The Edison award underscores the significance of the Simplexa and 3M